Literature DB >> 16162344

Mutation of the extracellular domain of tumour necrosis factor receptor 1 causes reduced NF-kappaB activation due to decreased surface expression.

Stefan Siebert1, Ceri A Fielding, Bryan D Williams, Paul Brennan.   

Abstract

Tumour necrosis factor receptor-associated periodic syndrome (TRAPS) results from point mutations in the extracellular domain of TNF receptor 1 (TNFRSF1A), but the effects of the mutations are controversial. This study shows that reduced NF-kappaB signalling is a feature of four TRAPS mutations. Reduced signalling correlates with reduced surface expression, measured by flow cytometry and microscopy. This suggests that correct formation of the extracellular domain of TNFRSF1A is important for localisation and receptor function. Importantly, our data provides a mechanism for the reduced TNFRSF1 signalling observed in a patient cell line.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162344     DOI: 10.1016/j.febslet.2005.08.037

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS).

Authors:  Adrian A Lobito; Fiona C Kimberley; Jagan R Muppidi; Hirsh Komarow; Adrianna J Jackson; Keith M Hull; Daniel L Kastner; Gavin R Screaton; Richard M Siegel
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

2.  Role of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.

Authors:  A Caminero; M Comabella; X Montalban
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

3.  Noncompetitive Allosteric Antagonism of Death Receptor 5 by a Synthetic Affibody Ligand.

Authors:  Nagamani Vunnam; Sophia Szymonski; Petra Hirsova; Gregory J Gores; Jonathan N Sachs; Benjamin J Hackel
Journal:  Biochemistry       Date:  2020-09-30       Impact factor: 3.162

4.  Skin manifestations in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).

Authors:  Rebecca Schmaltz; Thomas Vogt; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2010-01

5.  Tumor necrosis factor receptor-associated periodic syndrome: toward a molecular understanding of the systemic autoinflammatory diseases.

Authors:  John G Ryan; Ivona Aksentijevich
Journal:  Arthritis Rheum       Date:  2009-01

Review 6.  Autophagy dysfunction in autoinflammatory diseases.

Authors:  Yichao Hua; Min Shen; Christine McDonald; Qingping Yao
Journal:  J Autoimmun       Date:  2017-11-03       Impact factor: 7.094

7.  An Innovative High-Throughput Screening Approach for Discovery of Small Molecules That Inhibit TNF Receptors.

Authors:  Chih Hung Lo; Nagamani Vunnam; Andrew K Lewis; Ting-Lan Chiu; Benjamin E Brummel; Tory M Schaaf; Benjamin D Grant; Prachi Bawaskar; David D Thomas; Jonathan N Sachs
Journal:  SLAS Discov       Date:  2017-05-22       Impact factor: 3.341

Review 8.  Modulation of tumor necrosis factor by microbial pathogens.

Authors:  Masmudur M Rahman; Grant McFadden
Journal:  PLoS Pathog       Date:  2006-02       Impact factor: 6.823

Review 9.  Falling into TRAPS--receptor misfolding in the TNF receptor 1-associated periodic fever syndrome.

Authors:  Fiona C Kimberley; Adrian A Lobito; Richard M Siegel; Gavin R Screaton
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS).

Authors:  Ola H Negm; Heiko A Mannsperger; Elizabeth M McDermott; Elizabeth Drewe; Richard J Powell; Ian Todd; Lucy C Fairclough; Patrick J Tighe
Journal:  Eur J Immunol       Date:  2014-06-10       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.